I’ve recently had the pleasure of acting as RPS spokesperson for the MHRA Yellow Card Scheme, which acts as an early warning system for the identification of previously unrecognised drug reactions. Read more »

By Neal Patel, Head of Corporate Communications

As part of our commitment to patient safety, we’re proud to be involved in the Real Danger campaign, which aims to raise awareness of the dangers of buying prescription medicine online without a consultation with a heath professional or proper authority. We took part in important research that resulted in some alarming statistics:

Read more »

By Dr Anthony R Cox, Lecturer in Clinical Pharmacy University of Birmingham

This week David Cameron set out plans to open up NHS data, by making the sharing of NHS patient data for research the default position within the NHS. This initiative will save lives.

The focus of the media has been on the ability of the pharmaceutical industry to exploit the data for profit, and with modern day cynicism about the industry & concern about current NHS reforms it isn’t surprising to see this painted as an attempt to “privatize” the NHS. Others are concerned about the confidentiality of the data, in part fed by the same campaigners who opposed the now scrapped ID card. Read more »